Glaxosmithkline Share Price | |
---|---|
Price | 1,413.60 |
Bid | 1,412.60 |
Ask | 1,413.00 |
Change | 20.20 (1.45%) |
Volume | 8,007,107 |
Open | 1,385.80 |
High | 1,414.00 |
Low | 1,380.20 |
Close | 1,393.40 |
Currency | GBX |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 5,017m |
Market Capitalisation | £70,926m |
Market Size | 1,000 |
52 Week High | 1,857.00 |
52 Week High Date | 24-Jan-2020 |
52 Week Low | 1,284.00 |
52 Week Low Date | 30-Oct-2020 |
# Trades | 13,051 |
---|---|
Vol. Sold | 5,920,183 |
Sold Value | £84m |
Vol. Bought | 1,659,650 |
Bought Value | £23m |
PE Ratio | 15.054 |
Earnings | 93.90 |
Dividend | 80.00 |
Yield | 5.659% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
15-Jan-21 | 18:28:23 | 1,405.05 | 4,987 | Sell* | 1,412.60 | 1,413.00 | 70.07k | O Ordinary |
15-Jan-21 | 18:28:14 | 1,385.48 | 1,663 | Sell* | 1,412.60 | 1,413.00 | 23.04k | O Ordinary |
15-Jan-21 | 17:47:48 | 1,400.972 | 19,854 | Sell* | 1,412.60 | 1,413.00 | 278.15k | O Ordinary |
15-Jan-21 | 17:53:55 | 1,413.423 | 4,673 | Buy* | 1,412.60 | 1,413.00 | 66.05k | O Ordinary |
15-Jan-21 | 17:49:35 | 1,398.327 | 7,279 | Sell* | 1,412.60 | 1,413.00 | 101.78k | O Ordinary |
15-Jan-21 | 17:44:40 | 1,406.139 | 3,150 | Sell* | 1,412.60 | 1,413.00 | 44.29k | O Ordinary |
15-Jan-21 | 17:43:30 | 1,386.861 | 1 | Sell* | 1,412.60 | 1,413.00 | 13.87 | O Ordinary |
15-Jan-21 | 17:40:16 | 1,385.60 | 1,921 | Sell* | 1,412.60 | 1,413.00 | 26.62k | O Ordinary |
15-Jan-21 | 17:42:21 | 1,406.376 | 317 | Sell* | 1,412.60 | 1,413.00 | 4,458 | O Ordinary |
15-Jan-21 | 17:20:13 | 1,400.748 | 3,334 | Sell* | 1,412.60 | 1,413.00 | 46.70k | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Jan-21 | 14-Jan-21 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade. Emma Walmsley | 1,387.19 | GBX | 28 | 3,155,258 |
13-Jan-21 | 12-Jan-21 | Transfer From | Emma Walmsley held the position of CEO at the time of this trade. Emma Walmsley | 0.00 | 9 | 3,155,230 | |
13-Jan-21 | 12-Jan-21 | Buy | Emma Walmsley held the position of CEO at the time of this trade. Emma Walmsley | 1,384.25 | GBX | 9 | 3,155,230 |
11-Jan-21 | 07-Jan-21 | Buy | Hal Barron held the position of Chief Scientific Officer at the time of this trade. Hal Barron | 19.03 | USD | 2,169 | 11,005 |
11-Jan-21 | 07-Jan-21 | Buy | Hal Barron held the position of Chief Scientific Officer at the time of this trade. Hal Barron | 19.03 | USD | 388 | 11,005 |
The homepage of the GSK global corporate website